Persistent cloudiness or visible particles indicate a problem
Neri S, Pistone G, Saraceno B, et al
Some people may need to stay on a maintenance dose of a GLP-1 Receptor Agonist for a while to be able to manage their weight effectively, but as long as side effects are minimal or tolerable, this should be manageable under the supervision of a prescriber
Sometimes its easier to do by yourself than other times
As recently highlighted at the ACS Clinical Congress 2025, bariatric surgery was originally developed as a weight-loss procedure yet we discovered it could improve or even resolve type 2 diabetes
Medicare does not cover GLP-1 medications for weight loss under Part D, although the Medicare Bridge Program launched July 1, 2026 provides $50 per month for Wegovy pen, Wegovy pill, Zepbound KwikPen, and Foundayo for eligible Medicare beneficiaries with BMI 27 and above and an obesity-related comorbidity, running through December 31, 2027 (PeptideDeck)